BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tilg H, Adolph TE, Trauner M. Gut-liver axis: Pathophysiological concepts and clinical implications. Cell Metab 2022;34:1700-18. [PMID: 36208625 DOI: 10.1016/j.cmet.2022.09.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Rager SL, Zeng MY. The Gut–Liver Axis in Pediatric Liver Health and Disease. Microorganisms 2023;11:597. [DOI: 10.3390/microorganisms11030597] [Reference Citation Analysis]
2 Greten TF, Schwabe R, Bardeesy N, Ma L, Goyal L, Kelley RK, Wang XW. Immunology and immunotherapy of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2023. [PMID: 36697706 DOI: 10.1038/s41575-022-00741-4] [Reference Citation Analysis]
3 Akl MG, Widenmaier SB. Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma. Front Cell Dev Biol 2022;10:1089124. [PMID: 36712976 DOI: 10.3389/fcell.2022.1089124] [Reference Citation Analysis]
4 Habtemariam S. The Molecular Pharmacology of Phloretin: Anti-Inflammatory Mechanisms of Action. Biomedicines 2023;11. [PMID: 36672652 DOI: 10.3390/biomedicines11010143] [Reference Citation Analysis]
5 Becker C, Adolph TE. Disentangling tryptophan metabolism in inflammatory bowel diseases. Gut 2023:gutjnl-2022-328853. [PMID: 36596710 DOI: 10.1136/gutjnl-2022-328853] [Reference Citation Analysis]
6 Liu C, Su W, Tan Z, Zhang J, Dong W. The interaction between microbiota and immune in intestinal inflammatory diseases: Global research status and trends. Front Cell Infect Microbiol 2023;13:1128249. [PMID: 36824689 DOI: 10.3389/fcimb.2023.1128249] [Reference Citation Analysis]
7 Zhou Z, Li K, Guo J, Wang Y, Wei Y, Duan J, Chen M, Shi L, Hu W. Green Tea Catechin EGCG Ameliorates Thioacetamide-Induced Hepatic Encephalopathy in Rats via Modulation of the Microbiota-Gut-Liver Axis. Mol Nutr Food Res 2022;:e2200821. [PMID: 36573265 DOI: 10.1002/mnfr.202200821] [Reference Citation Analysis]
8 李 玉. Relationship between Gut Microbiota and Development and Prognosis of Autoimmune Liver Disease. ACM 2022;12:10814-10821. [DOI: 10.12677/acm.2022.12111557] [Reference Citation Analysis]